MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Fesoterodine

Fesoterodine 4mg modified-release tablets

Incompatible

Stability notes for Fesoterodine 4mg modified-release tablets

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 4mg modified-release tablets (Pfizer Ltd).

Suppliers (8) of Fesoterodine 4mg modified-release tablets
Fesoterodine 4mg modified-release tablets (A A H Pharmaceuticals Ltd)
Fesoterodine 4mg modified-release tablets (Accord-UK Ltd)
Fesoterodine 4mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Fesoterodine 4mg modified-release tablets (Aspire Pharma Ltd)
Fesoterodine 4mg modified-release tablets (Genus Pharmaceuticals Ltd)
Fesoterodine 4mg modified-release tablets (Medihealth (Northern) Ltd)
Toviaz 4mg modified-release tablets (CST Pharma Ltd)
Toviaz 4mg modified-release tablets (Pfizer Ltd)

Fesoterodine 8mg modified-release tablets

Incompatible

Stability notes for Fesoterodine 8mg modified-release tablets

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 8mg modified-release tablets (Pfizer Ltd).

Suppliers (7) of Fesoterodine 8mg modified-release tablets
Fesoterodine 8mg modified-release tablets (A A H Pharmaceuticals Ltd)
Fesoterodine 8mg modified-release tablets (Accord-UK Ltd)
Fesoterodine 8mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Fesoterodine 8mg modified-release tablets (Aspire Pharma Ltd)
Fesoterodine 8mg modified-release tablets (Genus Pharmaceuticals Ltd)
Fesoterodine 8mg modified-release tablets (Medihealth (Northern) Ltd)
Toviaz 8mg modified-release tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.